Literature DB >> 29200349

Mortality Quadrupled Among Opioid-Driven Hospitalizations, Notably Within Lower-Income And Disabled White Populations.

Zirui Song1.   

Abstract

Hospitals play an important role in caring for patients in the current opioid crisis, but data on the outcomes and composition of opioid-driven hospitalizations in the United States have been lacking. Nationally representative all-payer data for the period 1993-2014 from the National Inpatient Sample were used to compare the mortality rates and composition of hospitalizations with opioid-related primary diagnoses and those of hospitalizations for other drugs and for all other causes. Mortality among opioid-driven hospitalizations increased from 0.43 percent before 2000 to 2.02 percent in 2014, an average increase of 0.12 percentage points per year relative to the mortality of hospitalizations due to other drugs-which was unchanged. While the total volume of opioid-driven hospitalizations remained relatively stable, it shifted from diagnoses mostly involving opioid dependence or abuse to those centered on opioid or heroin poisoning (the latter have higher case fatality rates). After 2000, hospitalizations for opioid/heroin poisoning grew by 0.01 per 1,000 people per year, while hospitalizations for opioid dependence or abuse declined by 0.01 per 1,000 people per year. Patients admitted for opioid/heroin poisoning were more likely to be white, ages 50-64, Medicare beneficiaries with disabilities, and residents of lower-income areas. As the United States combats the opioid epidemic, efforts to help hospitals respond to the increasing severity of opioid intoxication are needed, especially in vulnerable populations.

Entities:  

Keywords:  Disparities; Health Policy; Hospitals; Mortality; Opioids

Mesh:

Substances:

Year:  2017        PMID: 29200349      PMCID: PMC5814297          DOI: 10.1377/hlthaff.2017.0689

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  28 in total

1.  Comparison of the Elixhauser and Charlson/Deyo methods of comorbidity measurement in administrative data.

Authors:  Danielle A Southern; Hude Quan; William A Ghali
Journal:  Med Care       Date:  2004-04       Impact factor: 2.983

2.  Assessing the accuracy of opioid overdose and poisoning codes in diagnostic information from electronic health records, claims data, and death records.

Authors:  Carla A Green; Nancy A Perrin; Shannon L Janoff; Cynthia I Campbell; Howard D Chilcoat; Paul M Coplan
Journal:  Pharmacoepidemiol Drug Saf       Date:  2017-01-10       Impact factor: 2.890

3.  Moving beyond misuse and diversion: the urgent need to consider the role of iatrogenic addiction in the current opioid epidemic.

Authors:  Gillian A Beauchamp; Erin L Winstanley; Shawn A Ryan; Michael S Lyons
Journal:  Am J Public Health       Date:  2014-09-11       Impact factor: 9.308

4.  President Obama Proposes $1.1 Billion in New Funding to Address the Prescription Opioid Abuse and Heroin Use Epidemic.

Authors: 
Journal:  J Pain Palliat Care Pharmacother       Date:  2016-06

5.  Prescription opioid use among disabled Medicare beneficiaries: intensity, trends, and regional variation.

Authors:  Nancy E Morden; Jeffrey C Munson; Carrie H Colla; Jonathan S Skinner; Julie P W Bynum; Weiping Zhou; Ellen Meara
Journal:  Med Care       Date:  2014-09       Impact factor: 2.983

6.  Increases in Fentanyl-Related Overdose Deaths - Florida and Ohio, 2013-2015.

Authors:  Alexis B Peterson; R Matthew Gladden; Chris Delcher; Erica Spies; Amanda Garcia-Williams; Yanning Wang; John Halpin; Jon Zibbell; Carolyn Lullo McCarty; Jolene DeFiore-Hyrmer; Mary DiOrio; Bruce A Goldberger
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

7.  Fentanyl Law Enforcement Submissions and Increases in Synthetic Opioid-Involved Overdose Deaths - 27 States, 2013-2014.

Authors:  R Matthew Gladden; Pedro Martinez; Puja Seth
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2016-08-26       Impact factor: 17.586

8.  Drug-poisoning Deaths Involving Opioid Analgesics: United States, 1999-2011.

Authors:  Li Hui Chen; Holly Hedegaard; Margaret Warner
Journal:  NCHS Data Brief       Date:  2014-09

9.  Use of diagnosis codes for detection of clinically significant opioid poisoning in the emergency department: A retrospective analysis of a surveillance case definition.

Authors:  Joseph M Reardon; Katherine J Harmon; Genevieve C Schult; Catherine A Staton; Anna E Waller
Journal:  BMC Emerg Med       Date:  2016-02-08

10.  Vital Signs: Demographic and Substance Use Trends Among Heroin Users - United States, 2002-2013.

Authors:  Christopher M Jones; Joseph Logan; R Matthew Gladden; Michele K Bohm
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2015-07-10       Impact factor: 17.586

View more
  28 in total

1.  Assessment of Racial/Ethnic and Income Disparities in the Prescription of Opioids and Other Controlled Medications in California.

Authors:  Joseph Friedman; David Kim; Todd Schneberk; Philippe Bourgois; Michael Shin; Aaron Celious; David L Schriger
Journal:  JAMA Intern Med       Date:  2019-04-01       Impact factor: 21.873

2.  Patient-Reported Outcomes of an Integrative Pain Management Program Implemented in a Primary Care Safety Net Clinic: a Quasi-experimental Study.

Authors:  Maria Teresa Chao; Emily Hurstak; Kristina Leonoudakis-Watts; Frank Sidders; Joseph Pace; Hali Hammer; Barbara Wismer
Journal:  J Gen Intern Med       Date:  2019-07       Impact factor: 5.128

3.  US National Trends in Opioid-Related Hospitalizations Among Patients With Cancer.

Authors:  Isaac S Chua; Richard E Leiter; Kate T Brizzi; Charles A Coey; Emanuele Mazzola; James A Tulsky; Charlotta Lindvall
Journal:  JAMA Oncol       Date:  2019-05-01       Impact factor: 31.777

Review 4.  Clinical Perspective on Opioids in the Context of Suicide Risk.

Authors:  Paul S Nestadt; Amy S B Bohnert
Journal:  Focus (Am Psychiatr Publ)       Date:  2020-04-23

5.  Binge Drinking and Prescription Opioid Misuse in the U.S., 2012-2014.

Authors:  Marissa B Esser; Gery P Guy; Kun Zhang; Robert D Brewer
Journal:  Am J Prev Med       Date:  2019-06-11       Impact factor: 5.043

6.  Opioid use disorder research and the Council for the Advancement of Nursing Science priority areas.

Authors:  Patricia Eckardt; Donald Bailey; Holli A DeVon; Cynthia Dougherty; Pamela Ginex; Cheryl A Krause-Parello; Rita H Pickler; Therese S Richmond; Eleanor Rivera; Carol F Roye; Nancy Redeker
Journal:  Nurs Outlook       Date:  2020-04-09       Impact factor: 3.250

7.  Mortality Following Nonfatal Opioid and Sedative/Hypnotic Drug Overdose.

Authors:  Sidra Goldman-Mellor; Mark Olfson; Cristina Lidon-Moyano; Michael Schoenbaum
Journal:  Am J Prev Med       Date:  2020-05-07       Impact factor: 5.043

8.  Opioid Prescribing After Opioid-related Inpatient Hospitalizations by Diagnosis: A Cohort Study.

Authors:  Pooja A Lagisetty; Lewei A Lin; Dara Ganoczy; Rebecca L Haffajee; Theodore J Iwashyna; Amy S B Bohnert
Journal:  Med Care       Date:  2019-10       Impact factor: 2.983

9.  US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011-2015.

Authors:  Cora Peterson; Likang Xu; Christina A Mikosz; Curtis Florence; Karin A Mack
Journal:  J Subst Abuse Treat       Date:  2018-06-20

10.  Which patients receive an addiction consult? A preliminary analysis of the INREACH (INpatient REadmission post-Addiction Consult Help) study.

Authors:  Maria J D'Amico; Alexander Y Walley; Debbie M Cheng; Leah S Forman; Danny Regan; Alexandra Yurkovic; Jeffrey H Samet; Zoe M Weinstein
Journal:  J Subst Abuse Treat       Date:  2019-08-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.